Oppenheimer Inc. (OPY)

Nvidia (NVDA) could be set to gain from growing demand for sovereign AI, Oppenheimer analysts said, after CEO Jensen Huang toured Europe last week and announced new deals and partnerships.

Oppenheimer analyst Leland Gershell raised the firm's price target on UroGen Pharma to $31 from $10 and keeps an Outperform rating on the shares following yesterday's approval of Zusduri. The firm say...

Squarepoint Ops LLC bought a new position in Abeona Therapeutics Inc (NASDAQ:ABEO – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securitie...

LOS ANGELES--(BUSINESS WIRE)---- $NAGE #InvestorRelations--Niagen Bioscience, Inc. (NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a fo...

LOS ANGELES--(BUSINESS WIRE)--Motorcar Parts of America, Inc. (Nasdaq:MPAA) today announced it is scheduled for a fireside chat presentation on Wednesday, June 11, 2025 at 10:30 a.m. Eastern time at t...

HANOVER, Pa.--(BUSINESS WIRE)--Utz Brands, Inc. (NYSE: UTZ) (“Utz” or the “Company”), a leading U.S. manufacturer of branded Salty Snacks and a small-cap value Staples equity, announced today that the...

WALNUT CREEK, Calif.--(BUSINESS WIRE)---- $CENT #Garden--Central Garden & Pet Company (NASDAQ: CENT), (NASDAQ: CENTA), (“Central”), a market leader in the pet and garden industries, today announced it...

LOUISVILLE, Ky.--(BUSINESS WIRE)--Papa John's International, Inc. (Nasdaq: PZZA) (“Papa Johns®”) today announced that members of its leadership team will participate in the 2025 Oppenheimer Consumer G...

07 Aug